Antonazzo, Ippazio Cosimo
Gribaudo, Giorgia
La Vecchia, Adriano
Ferrara, Pietro
Piraino, Alexandra
Cortesi, Paolo Angelo
Mantovani, Lorenzo Giovanni
Article History
Accepted: 11 August 2024
First Online: 24 August 2024
Declarations
:
: Conceptualisation: I.C.A., P.A.C., L.G.M. Methodology: I.C.A., G.G., A.L.V, P.A.C. Data curation: I.C.A. G.G., A.L.V. Writing—original draft preparation: I.C.A., G.G., P.F, P.A.C. Writing—review and editing, all authors. All authors have read and agreed to the published version of the manuscript.
: No funding was received for the preparation of this article.
: Not applicable.
: Not applicable.
: I.C.A., G.G., A.L.V., P.F, A.P. declare no conflicts of interest. P.A.C. has received a research grant from Baxalta, now part of Shire, and speaking honoraria from Pfizer and Roche. L.G.M. has received grants and personal fees from Bayer AG, Boehringer Ingelheim, Pfizer and Daiichi-Sankyo.